Activities of Linea SØGAARD-LIDELL related to 2020/0102(COD)
Plenary speeches (1)
Programme for the Union’s action in the field of health for the period 2021-2027 (‘EU4Health programme’) (debate)
Amendments (33)
Amendment 131 #
Proposal for a regulation
Recital 5 b (new)
Recital 5 b (new)
Amendment 192 #
Proposal for a regulation
Recital 12
Recital 12
(12) With a view to protect people in vulnerable situations, including those suffering from mental illnesses and chronic diseases, such as obesity, cancer, diabetes, cardiovascular disease and neurologic disorder, the Programme should also promote actions which address the collateral impacts of the health crisis on people belonging to such vulnerable groups.
Amendment 231 #
Proposal for a regulation
Recital 15 a (new)
Recital 15 a (new)
(15a) The programme should support innovations in the digitalization area that could bring concrete benefits to patients and healthcare professionals and provide cost-effective high-quality healthcare whilst reducing inequalities. Important steps could be taken in digital skills, both for healthcare professionals and patients training, especially in rural and sparsely populated areas.
Amendment 234 #
Proposal for a regulation
Recital 15 b (new)
Recital 15 b (new)
(15b) The programme should facilitate the reinforcement of e-health and m- health as well as the use of telemedicine and remote monitoring of patients, especially in times of sanitary crises.
Amendment 252 #
Proposal for a regulation
Recital 17
Recital 17
(17) Non-communicable diseases are a result of a combination of genetic, physiological, environmental and behavioural factors. Such non- communicable diseases as cardiovascular diseases, cancer, obesity, chronic respiratory diseases, and diabetes, and neurologic disorder represent major causes of disability, ill-health, health- related retirement, and premature death in the Union, resulting in considerable social and economic impacts. To decrease the impact of non-communicable diseases on individuals and society in the Union and reach goal 3 of the Sustainable Development Goals, Target 3.4, to reduce premature mortality from non- communicable diseases by one third by 2030, it is key to provide an integrated response focusing on prevention across sectors and policy fields, combined with efforts to strengthen health systems.
Amendment 260 #
Proposal for a regulation
Recital 17 a (new)
Recital 17 a (new)
(17a) Chronic diseases develop slowly, are long-lasting and often incurable. Chronic disease patients often live with several comorbidities, which makes it complex to treat and manage them. The Union and the Member States can greatly reduce the burden on Member States by working together to achieve a better and more effective management of diseases, and the Programme should support actions in this area. The Programme should support the development of specific European Diseases Management Guidelines, for diseases such as cardiovascular disease, neurodegenerative diseases, respiratory diseases, obesity and diabetes. In making these guidelines, special attention should be given to major risk factors such as tobacco use, alcohol consumption, unhealthy diet, physical inactivity and air quality.
Amendment 276 #
Proposal for a regulation
Recital 18
Recital 18
(18) The Programme therefore should contribute to disease prevention throughout the lifetime of an individual and to health promotion by addressing health risk factors, such as the use of tobacco and related products and exposure to their emissions, the harmful use of alcohol, and the consumption of illicit drugs. The Programme should also contribute to the reduction of drugs-related health damage, unhealthy dietary habits and, physical inactivity and obesity, and exposure to environmental and indoor pollution, and foster supportive environments for healthy lifestyles in order to complement Member States action in these areas. The Programme should also therefore contribute to the objectives of the European Green Deal, the Farm to Fork Strategy and, the Biodiversity Strategy and the Chemicals strategy for sustainability.
Amendment 277 #
Proposal for a regulation
Recital 18
Recital 18
(18) The Programme therefore should contribute to disease prevention throughout the lifetime of an individual and to health promotion by addressing health risk factors, such as the use of tobacco and related products and exposure to their emissions, the harmful use of alcohol, and the consumption of illicit drugs. The Programme should also contribute to the reduction of drugs-related health damage, obesity, unhealthy dietary habits and physical inactivity, and exposure to environmental pollution, and foster supportive environments for healthy lifestyles in order to complement Member States action in these areas. The Programme should also therefore contribute to the objectives of the European Green Deal, the Farm to Fork Strategy and, the Biodiversity Strategy and Chemicals Strategy for Sustainability.
Amendment 294 #
Proposal for a regulation
Recital 18 b (new)
Recital 18 b (new)
(18b) Vaccination prevents an estimated 2,5 million deaths each year worldwide and reduces disease-specific treatment costs. The introduction of large-scale protective vaccinations in Europe has significantly contributed to the eradication or decline of many infectious diseases. Nevertheless, the worrying phenomenon of vaccine hesitancy and the disinformation on vaccination should be addressed by the Programme to reassure European citizens.
Amendment 296 #
Proposal for a regulation
Recital 19
Recital 19
(19) Cancer is the second leading cause of mortality in the Member States after cardiovascular diseases. Cancer is caused by many factors in multiple stages and therefore requires a new prevention paradigm that addresses individual health determinants (genetic, lifestyle) and wider (populations) determinants related to occupational, environmental and social exposure factors; It is also one of non- communicable diseases that share common risk factors with others and the prevention and control of which would benefit the majority of citizens. Poor nutrition, physical inactivity, obesity, tobacco and alcohol are risk factors common to other chronic diseases, such as cardiovascular diseases, type 2 diabetes, and respiratory diseases, and therefore cancer prevention programmes should be conducted within the context of an integrated chronic disease prevention programme. In 2020 the Commission announced the ‘Europe’s Beating Cancer Plan’ which would cover the entire cyclevery key stage of the disease starting from prevention and early diagnosis to tre:prevention, diagnosis, treatment, life as a cancer survivor, reinsertion and palliative care. The programme should promote actions to improve cancer patmient and quality of life of patients and survivorss' rights including the return to work with a disability, the right to be forgotten, the access to preserved fertility and provide optimal relief during the end-of-life stage. The measures should benefit from the Programme and from Horizon Europe’s Mission on Cancer. which will work in close link.
Amendment 304 #
Proposal for a regulation
Recital 19
Recital 19
(19) Cancer iscauses 26 % of all deaths in EU and is thereby the second leading cause of mortality in the Member States after cardiovascular diseases that represent 36 % of all deaths in the EU. It is also one of non-communicable diseases that share common risk factors such as obesity for 20 % of cancers and the prevention and control of which would benefit the majority of citizens. In 2020 the Commission announced the ‘Europe’s Beating Cancer Plan’ which would cover the entire cycle of the disease starting from prevention and early diagnosis to treatment and quality of life of patients and survivors. The measures should benefit from the Programme and from Horizon Europe’s Mission on Cancer.
Amendment 315 #
Proposal for a regulation
Recital 19 a (new)
Recital 19 a (new)
(19a) The Programme should ensure that patients living with and suffering from any chronic disease such as cardiovascular disease, cancer, obesity, chronic respiratory disease, neurologic disorder, diabetes or mental health disorder benefit from it in a proportionate manner.
Amendment 396 #
Proposal for a regulation
Recital 27 a (new)
Recital 27 a (new)
(27a) The programme should support the EU-wide mobility of healthcare professionals, during both their education and professional careers through Erasmus + fundings, and of their particular role in improving knowledge and expertise on health threats. The programme should also facilitate the implementation of the Professional Qualifications Directive to ensure better mutual recognition of qualifications of health professionals within the Union.
Amendment 401 #
Proposal for a regulation
Recital 27 d (new)
Recital 27 d (new)
(27d) The Programme should take concrete actions against rare, complex and low-prevalence diseases. Early detection must be facilitated and projects such as “Rare 2030” encouraging with the objective to set up concrete and innovative policies for developing research and improving the lives of patients.
Amendment 413 #
Proposal for a regulation
Recital 36
Recital 36
(36) Cooperation with third countries should be strengthened on the exchange of knowledge and best practices in health systems preparedness and response. The programme should help building a strong and effective partnership between the Union and Africa and prioritise health systems strengthening, universal access to health services and global health research and development in the framework of the EU-Africa Strategy.
Amendment 565 #
Proposal for a regulation
Article 4 – paragraph 1 – point 6
Article 4 – paragraph 1 – point 6
(6) support action for the surveillance, prevention, diagnosis and treatment and care of non-communicable diseases, and notably of cancerincluding cancer, obesity, cardiovascular disease, chronic respiratory disease, diabetes, neurologic disorder and mental health conditions;
Amendment 573 #
Proposal for a regulation
Article 4 – paragraph 1 – point 6 a (new)
Article 4 – paragraph 1 – point 6 a (new)
(6a) support actions to raise awareness chronic neurological disorders, including migraine, to develop ad-hoc strategies to ensure integration patients at work and more broadly in society, as well as to ensure timely and quality diagnosis and access to available treatments;
Amendment 655 #
Proposal for a regulation
Article 20 – paragraph 2
Article 20 – paragraph 2
2. The interim evaluation of the Programme shall be performed and submitted to the European Parliament and to the Council once there is sufficient information available about their implementation, but not later than four years after the start of the implementation.
Amendment 656 #
Proposal for a regulation
Article 20 – paragraph 3
Article 20 – paragraph 3
3. At the end of the implementation period, but no later than four years after the end of the period specified in Article 1, a final evaluation shall be carried out by the Commission and submitted to the European Parliament and to the Council.
Amendment 657 #
Proposal for a regulation
Article 20 – paragraph 4
Article 20 – paragraph 4
4. The Commission shall publish and communicate the conclusions of the evaluations accompanied by its observations, and shall present them to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions.
Amendment 847 #
Proposal for a regulation
Annex I – point h – introductory part
Annex I – point h – introductory part
(h) Actions on cancer and other major chronic diseases:
Amendment 853 #
Proposal for a regulation
Annex I – point h – point i
Annex I – point h – point i
(i) Support Member States and NGOs in the promotion and implementation of the recommendations of the European Code against Cancer as well as WHO recommendations on preventing and controlling chronic diseases;
Amendment 859 #
Proposal for a regulation
Annex I – point h – point ii
Annex I – point h – point ii
(ii) Support the establishment of quality assurance schemes for cancer centres and for other disease specific centres;
Amendment 861 #
Proposal for a regulation
Annex I – point h – point iii
Annex I – point h – point iii
(iii) Support prevention programmes on the main cancer risk factors for cancer and other chronic diseases;
Amendment 868 #
Proposal for a regulation
Annex I – point h – point iv
Annex I – point h – point iv
(iv) Actions to support secondary prevention of cancer as well as chronic diseases, such as early detection and diagnosis through screening;
Amendment 879 #
Proposal for a regulation
Annex I – point h – point v
Annex I – point h – point v
(v) Actions supporting access to cancer and chronic disease services and to innovative medicines for cancer and other major chronic diseases;
Amendment 894 #
Proposal for a regulation
Annex I – point h – point vii
Annex I – point h – point vii
(vii) Actions supporting quality in cancer prevention against cancer and chronic diseases and care including diagnosis and treatment;
Amendment 901 #
Proposal for a regulation
Annex I – point h – point viii
Annex I – point h – point viii
(viii) Actions supporting the quality of life of cancer survivors, chronic disease patients and care givers;
Amendment 908 #
Proposal for a regulation
Annex I – point h – point x
Annex I – point h – point x
(x) Establishment and support of a mechanisms for cross-specialty capacity building and continuous education in the area of cancer and chronic disease care.
Amendment 928 #
Proposal for a regulation
Annex I – point i – point ii
Annex I – point i – point ii
(ii) Support actions to fight vaccine hesitancy and disinformation;
Amendment 1067 #
Proposal for a regulation
Annex II – part B – point 7
Annex II – part B – point 7
7. Ratio of Cancer Registries (CRs) and number of Member States (MSs) reporting information on cervical, breast, and colorectal cancer stage at diagnosis as well as other major chronic diseases
Amendment 1074 #
Proposal for a regulation
Annex II – part 2 – point 8 a (new)
Annex II – part 2 – point 8 a (new)
8a. Prevalence of overweight and obesity
Amendment 1088 #
Proposal for a regulation
Annex II – part 2 – point 14 a (new)
Annex II – part 2 – point 14 a (new)
14a. Prevalence of major chronic diseases as defined by WHO